These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 25255481)

  • 41. Ezetimibe--an update.
    Drug Ther Bull; 2009 Aug; 47(8):91-5. PubMed ID: 19654419
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ezetimibe/simvastatin: a guide to its clinical use in hypercholesterolemia.
    Lyseng-Williamson KA
    Am J Cardiovasc Drugs; 2012 Feb; 12(1):49-56. PubMed ID: 22208355
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quantitative determination of zopiclone and its impurity by four different spectrophotometric methods.
    Abdelrahman MM; Naguib IA; El Ghobashy MR; Ali NA
    Spectrochim Acta A Mol Biomol Spectrosc; 2015 Feb; 137():617-24. PubMed ID: 25244295
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Simvastatin-ezetimibe-induced hepatic failure necessitating liver transplantation.
    Tuteja S; Pyrsopoulos NT; Wolowich WR; Khanmoradi K; Levi DM; Selvaggi G; Weisbaum G; Tzakis AG; Schiff ER
    Pharmacotherapy; 2008 Sep; 28(9):1188-93. PubMed ID: 18752389
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Different resolution techniques for management of overlapped spectra: Application for the determination of novel co-formulated hypoglycemic drugs in their combined pharmaceutical dosage form.
    Moussa BA; Mahrouse MA; Fawzy MG
    Spectrochim Acta A Mol Biomol Spectrosc; 2018 Dec; 205():235-242. PubMed ID: 30025293
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel spectrophotometric methods for simultaneous determination of timolol and dorzolamide in their binary mixture.
    Lotfy HM; Hegazy MA; Rezk MR; Omran YR
    Spectrochim Acta A Mol Biomol Spectrosc; 2014 May; 126():197-207. PubMed ID: 24607469
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Simultaneous multicomponent analysis of overlapping spectrophotometric signals using a wavelet-based latent variable regression.
    Gao L; Ren S
    Spectrochim Acta A Mol Biomol Spectrosc; 2008 Dec; 71(3):959-64. PubMed ID: 18378491
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Dual inhibition of cholesterol using the drug combination ezetimibe/simvastatin?].
    Vaverková H
    Vnitr Lek; 2007 Apr; 53(4):421-7. PubMed ID: 17578178
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of simvastatin-ezetimibe combination therapy on adipose tissue hormones and systemic inflammation in patients with isolated hypercholesterolemia.
    Krysiak R; Zmuda W; Okopien B
    Cardiovasc Ther; 2014 Apr; 32(2):40-6. PubMed ID: 24354929
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of effects of ezetimibe/simvastatin versus simvastatin versus atorvastatin in reducing C-reactive protein and low-density lipoprotein cholesterol levels.
    Pearson T; Ballantyne C; Sisk C; Shah A; Veltri E; Maccubbin D
    Am J Cardiol; 2007 Jun; 99(12):1706-1713. PubMed ID: 17560879
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
    Ose L; Reyes R; Johnson-Levonas AO; Sapre A; Tribble DL; Musliner T
    Clin Ther; 2007 Nov; 29(11):2419-32. PubMed ID: 18158082
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bivariate versus multivariate smart spectrophotometric calibration methods for the simultaneous determination of a quaternary mixture of mosapride, pantoprazole and their degradation products.
    Hegazy MA; Yehia AM; Moustafa AA
    Pharmazie; 2013 May; 68(5):317-26. PubMed ID: 23802428
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ezetimibe + simvastatin (Merck/Schering-Plough).
    Flores NA
    Curr Opin Investig Drugs; 2004 Sep; 5(9):984-92. PubMed ID: 15503655
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Safety and efficacy of combined ezetimibe/simvastatin treatment and simvastatin monotherapy in patients with non-alcoholic fatty liver disease.
    Abel T; Fehér J; Dinya E; Eldin MG; Kovács A
    Med Sci Monit; 2009 Dec; 15(12):MS6-11. PubMed ID: 19946244
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ezetimibe/simvastatin.
    Montecucco F; Quercioli A; Mach F
    Expert Opin Drug Saf; 2009 Nov; 8(6):715-25. PubMed ID: 19968571
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes.
    Cannon CP; Giugliano RP; Blazing MA; Harrington RA; Peterson JL; Sisk CM; Strony J; Musliner TA; McCabe CH; Veltri E; Braunwald E; Califf RM;
    Am Heart J; 2008 Nov; 156(5):826-32. PubMed ID: 19061694
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The efficacy and safety of ezetimibe/simvastatin combination compared with intensified lipid-lowering treatment strategies in diabetic subjects with and without metabolic syndrome.
    Jimenez JG; Rosen JB; Pirags V; Massaad R; Hanson ME; Brudi P; Triscari J
    Diabetes Obes Metab; 2013 Jun; 15(6):513-22. PubMed ID: 23279632
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Simultaneous determination of lamivudine and stavudine in antiretroviral fixed dose combinations by first derivative spectrophotometry and high performance liquid chromatography.
    Kapoor N; Khandavilli S; Panchagnula R
    J Pharm Biomed Anal; 2006 Jun; 41(3):761-5. PubMed ID: 16464559
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification, isolation and characterization of process related impurities in ezetimibe.
    Guntupalli S; Ray UK; Murali N; Gupta PB; Kumar VJ; Satheesh D; Islam A
    J Pharm Biomed Anal; 2014 Jan; 88():385-90. PubMed ID: 24176742
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ezetimibe/simvastatin (INEGY) in the treatment of hyperlipidaemia.
    Kastelein JJ; Sankatsing RR
    Int J Clin Pract; 2005 Dec; 59(12):1464-71. PubMed ID: 16351680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.